Title	Publication Date	Language	Citations
Design Issues in Noninferiority/Equivalence Trials	1999/10/01	English	55
Effective Strategies for Maintaining Research Participation in Clinical Trials	2009/07/01	English	54
Statistical Assessment of Mean Differences between Two Dissolution Data Sets	1996/10/01	English	53
Evaluation of Indian Traditional Medicine	2001/04/01	English	50
A Meta-analysis to Assess the FDA DAVP’s TLOVR Algorithm in HIV Submissions	2011/05/01	English	49
A New Clinical Trial Design Combining Phases 2 and 3: Sequential Designs with Treatment Selection and a Change of Endpoint	2005/04/01	English	47
Innovation Deficit in the Pharmaceutical Industry	1996/01/01	English	47
Risk Perception of Prescription Drugs: Results of a National Survey	2007/01/01	English	47
Tests for Equivalence or Noninferiority Between Two Proportions	2000/04/01	English	44
On the Use of the Accelerated Failure Time Model As An Alternative to the Proportional Hazards Model in the Treatment of Time to Event Data: A Case Study in Influenza	2002/07/01	English	44
Implementing Adaptive Designs: Logistical and Operational Considerations	2006/10/01	English	43
Assessment of Consistency of Treatment Effects in Multiregional Clinical Trials	2010/09/01	English	43
Some Developments on the International Index of Erectile Function (IIEF)	1999/01/01	English	41
Consequences of Delayed Treatment Effects on Analysis of Time-to-Event Endpoints	2007/07/01	English	41
International Harmonization and Consensus DIA Meeting on Bioavailability and Bioequivalence Testing Requirements and Standards	1991/10/01	English	40
Public Health Care Management of Water Pollution with Pharmaceuticals: Environmental Classification and Analysis of Pharmaceutical Residues in Sewage Water	2005/07/01	English	39
Interim Monitoring of Group Sequential Trials Using Spending Functions for the Type I and Type II Error Probabilities	2001/10/01	English	39
Using Conjoint Analysis to Evaluate Health State Preferences	1999/07/01	English	39
A Behavioral Bayes Method for Determining the Size of a Clinical Trial	2000/04/01	English	39
Nonparametric Analysis of Covariance and Its Role in Noninferiority Clinical Trials	1999/10/01	English	39
A Quantitative Approach for Making Go/No-Go Decisions in Drug Development	2011/03/01	English	39
Aspects of Modernizing Drug Development Using Clinical Scenario Planning and Evaluation	2010/05/01	English	38
Measuring the Incidence, Causes, and Repercussions of Protocol Amendments	2011/05/01	English	37
The Use of Interim Analysis for Sample Size Adjustment	1993/07/01	English	37
Symptom Distress Checklists as a Component of Quality of Life Measurement: Comparing Prompted Reports by Patient and Physician with Concurrent Adverse Event Reports via the Physician	1994/01/01	English	36
Methods for Assessing the Credibility of Clinical Trial Outcomes	2001/10/01	English	36
Investigating Drug-Induced QT and QTc Prolongation in the Clinic: A Review of Statistical Design and Analysis Considerations: Report from the Pharmaceutical Research and Manufacturers of America QT Statistics Expert Team	2005/07/01	English	35
Practical Implementation of Bayesian Dose-Escalation Procedures	2003/01/01	English	35
Guidelines on Dissolution Profile Comparison	2001/07/01	English	34
Adaptive Dose-Response Studies	2006/10/01	English	34